This study is comparing 2 different types of routine surgery for prostate cancer that has a high risk of coming back. Doctors don’t know for sure if removing the lymph nodes reduces the chance of the ...

The two souls of Ljubljana merge in a new residential building In the two elevations of the Elipse building – an exact curve and a tormented series of wave-like terraces – the Austro-Hungarian rigor ...

Activant Solutions Inc. has agreed to buy the Intuit Eclipse Distribution Management Solutions business from Intuit for $100 million in cash. &nbsp ; Activant has identified the wholesale distribution ...

This study is comparing 2 different types of routine surgery for prostate cancer that has a high risk of coming back.

EX103: A newly designed CD20×CD3 molecule in heavily pre-treated patients with B-cell non-Hodgkin lymphoma from a phase I/II trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I ...

Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits ...

Aktien»Nachrichten»CENTURY THERAPEUTICS AKTIE»Century Therapeutics, Inc.: Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing ...

– Data presented at 65 th ASH Annual Meeting show CNTY-101 was generally well tolerated at Dose Level 1 (100 million cells) in a high-risk, heavily pretreated R/R B-cell lymphoma patient – – ...